Inovio Pharmaceuticals, Inc. (INO)

NASDAQ: INO · IEX Real-Time Price · USD
2.10
+0.04 (1.94%)
Jul 7, 2022 12:20 PM EDT - Market open
1.94%
Market Cap 480.99M
Revenue (ttm) 1.60M
Net Income (ttm) -328.33M
Shares Out 229.04M
EPS (ttm) -1.54
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,338,756
Open 2.05
Previous Close 2.06
Day's Range 2.02 - 2.11
52-Week Range 1.38 - 9.96
Beta 0.82
Analysts Buy
Price Target 5.10 (+142.9%)
Earnings Date Aug 8, 2022

About INO

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medic... [Read more...]

Industry Biotechnology
IPO Date Feb 12, 1998
CEO Jong Kim
Employees 317
Stock Exchange NASDAQ
Ticker Symbol INO
Full Company Profile

Financial Performance

In 2021, INO's revenue was $1.77 million, a decrease of -76.05% compared to the previous year's $7.41 million. Losses were -$303.66 million, 82.5% more than in 2020.

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for INO stock is "Buy." The 12-month stock price forecast is 5.1, which is an increase of 142.86% from the latest price.

Price Target
$5.1
(142.86% upside)
Analyst Consensus: Buy
Stock Forecasts

News

INOVIO Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PLYMOUTH MEETING, Pa. , July 1, 2022 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious diseases...

Why Inovio Pharmaceuticals Stock Topped the Market on Monday

The appointment of a new top executive clearly meets with investor approval.

INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer

PLYMOUTH MEETING, Pa. , June 27, 2022 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious disease...

7 Monkeypox Stocks That May Take Off in Q2

SIGA Technologies (SIGA) may lead on the list of monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race. The post 7 Monkeypox Stocks That May Take Off in Q2 appeared fi...

Other symbols: ABTCMRXEBSSIGATNXP

Stock Market Plunge: 2 Stocks to Avoid Right Now

Prudent investors should look elsewhere.

Other symbols: VXRT

Top Penny Stocks Today: What's Moving AVDL, BKSY, NILE, INO, & ALLR

Are these penny stocks to buy or avoid right now? The post Top Penny Stocks Today: What's Moving AVDL, BKSY, NILE, INO, & ALLR appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS...

Other symbols: ALLRAVDLBKSYNILE

INOVIO Announces Survival Results for INO-5401 + INO-9012 in Combination with Libtayo® (cemiplimab) in Patients with ...

INOVIO's DNA medicines immunotherapy in combination with Libtayo® elicits vaccine-associated immune responses when administered with RT/TMZ to newly diagnosed GBM patients INO-5401 + INO-9012 + Libtayo ...

7 Monkeypox Stocks to Watch Right Now

Wondering what are the best monkeypox stocks to watch? Here are the companies producing vaccines to help fight the spread of the virus.

Other symbols: CMRXEBSGOVXSIGATNXP

Why Inovio Pharmaceuticals Stock Is Rising Today

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher Monday amid increasing monkeypox concerns.  A monkeypox outbreak has been reported in at least a dozen countries.

INOVIO to Present at Jefferies 2022 Healthcare Conference

PLYMOUTH MEETING, Pa. , May 23, 2022 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious diseases ...

6 Stocks To Watch Amid Monkeypox Outbreak

A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts. What's going on?

Other symbols: CMRXEBSSIGATNXP

Is This Vaccine Stock in Trouble -- or Ready for a Rebound?

Inovio may be at a turning point.

Other symbols: AZNJNJMRNAPFE

INO Stock Plunges 25% as Inovio Pharmaceuticals Swaps Vaccine Focus

Inovio Pharmaceuticals has halted its Covid-19 progress to focus on a booster. Here's why this news is unlikely to boost INO stock.

Inovio lets go of CEO, to stop work on COVID-19 vaccine and instead focus on booster

Inovio Pharmaceuticals Inc.'s INO, +5.06% stock tumbled 21.7% in premarket trading on Wednesday, the day after the company said it will discontinue its work on a COVID-19 vaccine and will instead focus ...

Inovio Pharmaceuticals (INO) Reports Q1 Loss, Lags Revenue Estimates

Inovio (INO) delivered earnings and revenue surprises of -28.57% and 56.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

INOVIO Reports First Quarter 2022 Financial Results and Program Developments

Announces prioritization of heterologous booster strategy for COVID-19 vaccine candidate INO-4800 and discontinuation of Phase 3 INNOVATE trial to optimize potential impact on global public health Repor...

INOVIO Announces the Appointment of Jacqueline Shea, Ph.D., as Chief Executive Officer

Dr. Shea brings more than 25 years of leadership and industry expertise in life sciences and biotech PLYMOUTH MEETING, Pa., May 10, 2022 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company foc...

INOVIO to Report First Quarter 2022 Financial Results on May 10, 2022

PLYMOUTH MEETING, Pa. , April 26, 2022 /PRNewswire/ -- INOVIO (NASDAQ: INO) announced today that first quarter 2022 financial results will be released after the market close on May 10, 2022.

7 F-Rated Penny Stocks Not Worth the Gamble

It's a new market, and not every bargain is an opportunity to jump in. The post 7 F-Rated Penny Stocks Not Worth the Gamble appeared first on InvestorPlace.

Other symbols: BBLNHIPOORCQRTEAREE

2 Contenders in the Coronavirus Vaccine Market -- Are They Buys?

These two companies have been left in the dust. Is it too late for them?

Other symbols: VXRT

Geneos Therapeutics Secures $17 Million in Series A2 Financing to Advance Personalized Cancer Immunotherapy Platform

Geneos expands its Phase Ib/IIa clinical trial in lead indication for treating patients with advanced hepatocellular carcinoma Financing led by Flerie Invest and Dr. Ted Fjällman joins Geneos' Board of ...

2 Beaten-Down Stocks That Aren't Worth the Trouble

Some cheap stocks aren't bargains.

Other symbols: IQ

INOVIO to Present at Oppenheimer's 32nd Annual Healthcare Conference

PLYMOUTH MEETING, Pa., March 8, 2022 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious diseases ...

Could Inovio Win On This 1 Vaccine Detail?

This vaccine laggard suffered a new setback -- but there is one piece of good news.

Why Inovio Stock Tumbled on a Good Day for the Market Wednesday

The company's Q4 results didn't provide a lot of fuel for optimism.